FDA Panel Backs Proposed Epilepsy Drug Derived From Cannabis

An FDA advisory panel recommended approval of what could become the first prescription drug in the U.S. derived from the marijuana plant, as a treatment for people with rare forms of epilepsy.

from WSJ.com: US Business https://ift.tt/2HefrmE
via IFTTT